Remove 2003 Remove Analytical Chemistry Remove Clinical Development Remove Treatment
article thumbnail

BioSpace Movers & Shakers, Nov. 6

The Pharma Data

has been appointed to the additional role of president and will oversee the growth of the company’s technology portfolio for the treatment of ischemic and hemorrhagic stroke. Taveras will lead all research and non-clinical development functions supporting the company’s pipeline of investigational therapies. from 1993 to 1995.